Trial Information

Summary: BMT CTN #0501: Multi-Center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood Transplantation in Pediatric Patients with High Risk Leukemia and Myelodysplasia

You have/your child has been asked to participate in this research study because you are/your child is 2-21 years old, have/has leukemia or myelodysplastic syndrome (MDS) that has failed or is not likely to respond to other treatment, and suitable umbilical cord blood units are available for transplant.  The purpose of this study is to compare the use of two units of cord blood to one cord blood unit in terms of survival, relapse (return of disease), and side effects.  Your/your child’s participation in this study is expected to last about 2 months for treatment and about two years for follow-up.  Your/your child’s medical condition will be followed indefinitely.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: December 1, 2008 at 3:15:44 PM